Advertisement
Screener

Azitra, Inc. (AZTR) Form D

Azitra, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-09-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-09-10; Total offering amount $17,000,159.
  • 2017-03-20: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-03-17; Total offering amount $3,656,250.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-09-24Rule 506(b)Equity2020-09-10$17,000,159$17,000,159$08
2017-03-20Rule 506(b)Equity2017-03-17$3,656,250$2,900,010$756,2403

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medicus Pharma Ltd. (MDCX)$0.010B
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Theriva Biologics, Inc. (TOVX)United States$0.011B
KALA BIO, Inc. (KALA)United States$0.011B-3.33
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Dare Bioscience, Inc. (DARE)United States$0.011B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58